Skip to main content
SpringerLink
Log in

Do Systemically Administered Glutamate Antagonists Affect Subthalamic Nucleus Activity?

Relevance to pharmacotherapy of Parkinson’s disease

  • Conference paper
The Basal Ganglia VIII

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 56))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6. References

  • Allers, K.A., Kreiss, D.S., and Walters, J.R., 2000, Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion, Synapse 38:38.

    Article  PubMed  CAS  Google Scholar 

  • Allers, K.A., Ruskin, D.N., Bergstrom, D.A., Freeman, L.E., Ghazi, L.J., Tierney, P.L., and Walters, J.R., 2002, Multisecond periodicities in basal ganglia firing rates correlate with theta bursts in transcortical and hippocampal EEG, J. Neurophysiol. 87:1118.

    PubMed  Google Scholar 

  • Allers, K.A., Bergstrom, D.A., Ghazi, L.J., Kreiss, D.S., and Walters, J.R., 2005, MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson’s disease, Exptl. Neurol. 191:104.

    Article  CAS  Google Scholar 

  • Aubert, I., Guigoni, C., Hakansson, K., Ki, Q., Dovero, S., Barthe, N., Bioulac, B.H., Gross, C.E., Fisone, G., Bloch, B., and Bezard, E., 2004, Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia, Ann. Neurol. 57:17.

    Article  CAS  Google Scholar 

  • Bailey, E.V., and Stone, T.W., 1975, The mechanism of action of amantadine in parkinsonism: a review, Arch. Int. Pharmacodyn. Ther. 216:246.

    PubMed  CAS  Google Scholar 

  • Bergman, H., Wichmann, T., Karmon, B., and Delong, M.R., 1994, The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism, J. Neurophysiol. 72:507.

    PubMed  CAS  Google Scholar 

  • B’ezard, E., Boraud, T., Bioulac, B., and Gross, C.E., 1999, Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms, Eur. J. Neurosci. 11:2167.

    Article  CAS  Google Scholar 

  • Blanchet, P.J., Papa, S.M., Metman, L.V., Mouradian, M.M., and Chase, T.N., 1997, Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson’s disease, Neurosci. Biobehav. Rev. 21:447.

    Article  PubMed  CAS  Google Scholar 

  • Blanchet, P.J., Konitsiotis, S., Whittemore, E.R., Zhou, Z.L., Woodward, R.M., and Chase, T.N., 1999, Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys, J. Pharmacol. Exp. Ther. 290:1034.

    PubMed  CAS  Google Scholar 

  • Blanchet, P.J., 2003, The fluctuating parkinsonian patient — clinical and pathophysiological aspects, Can. J. Neurol. Sci. 30:S19.

    PubMed  Google Scholar 

  • Blanchet, P.J., Metman, L.V., and Chase, T.N., 2003, Renaissance of amantadine in the treatment of Parkinson’s disease, Adv. Neurol. 91:251.

    PubMed  CAS  Google Scholar 

  • Blanchini, F., Greenamyre, J.T., Fancellu, R., and Nappi, G., 2001, Blockade of subthalamic glutamatergic activity corrects changes in neuronal metabolism and motor behavior in rats with nigrostriatal lesions, Neurol. Sci. 22:49.

    Article  Google Scholar 

  • Breit, S., Bouali-Benazzouz, R., Benabid, A.L., and Benazzouz, A., 2001, Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat, Eur. J. Neurosci. 14:1833.

    Article  PubMed  CAS  Google Scholar 

  • Campbell, B.M., and Walker, P.D., 2001, MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression, Neuroreport 12:953.

    Article  PubMed  CAS  Google Scholar 

  • Clineschmidt, B.V., Martin, G.E., Bunting, P.R., and Papp, N.L., 1982, Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties, Drug. Dev. Res. 2:135.

    Article  CAS  Google Scholar 

  • Danielczyk, W., 1995, Twenty-five years of amantadine therapy in Parkinson’s disease, J. Neural. Transm. Suppl. 46:399.

    PubMed  CAS  Google Scholar 

  • Danysz, W., Parsons, C.G., Kornhuber, J., Schmidt, W.J., and Quack, G., 1997, Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies, Neurosci. Biobehav. Rev. 21:455.

    Article  PubMed  CAS  Google Scholar 

  • Dunah, A.W., Wang, Y.H., Yasuda, R.P., Kameyama, K., Huganir, R.L., Wolfe, B.B., and Standaert, D.G., 2000, Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-Daspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson’s disease, Mol. Pharmacol. 57:342.

    PubMed  CAS  Google Scholar 

  • Engber, T.M., Anderson, J.J., Boldry, R.C., Papa, S.M., Kuo, S., and Chase, T.N., 1994a, Excitatory aminoacid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopaminelesioned rats, Neuroscience 59:389.

    Article  PubMed  CAS  Google Scholar 

  • Engber, T.M., Papa, S.M., Boldry, R.C., and Chase, T.N., 1994b, NMDA receptor blockade reverses motor response alterations induced by levodopa, Neuroreport 5:2586.

    PubMed  CAS  Google Scholar 

  • Greenamyre, J.T., and O’Brien, C.F., 1991, N-methyl-D-aspartate antagonists in the treatment of Parkinson’s disease, Arch. Neurol. 48:977.

    PubMed  CAS  Google Scholar 

  • Hallett, P.J., and Standaert, D.G., 2004, Rationale for and use of NMDA receptor antagonists in Parkinson’s disease, Pharmacol. Therap. 102:155.

    Article  CAS  Google Scholar 

  • Hassani, O.K., Mouroux, M., and F’eger, J., 1996, Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus, Neuroscience 72:105.

    Article  PubMed  CAS  Google Scholar 

  • Hollerman, J.R., and Grace, A.A., 1992, Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol, Brain. Res. 590:291.

    Article  PubMed  CAS  Google Scholar 

  • Hu, D., Itoga C.A., Bergstrom, D.A., Parr-Brownlie, L.C., Ghiglieri V., and Walters, J.R., 2004, Increased patterned activity in basal ganglia outputs is organized by coordinated oscillations in the indirect pathway after dopamine loss in anesthetized rats, Soc. Neurosci. Abstr. 309:8.

    Google Scholar 

  • Huang, K.-X., and Walters, J.R., 1992, D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists, J. Pharmacol. Exp. Ther. 260:409.

    PubMed  CAS  Google Scholar 

  • Huang, K.-X., Bergstrom, D.A., Ruskin, D.N., and Walters, J.R., 1998, N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra, Synapse 30:18.

    Article  PubMed  CAS  Google Scholar 

  • Hutchison, W.D., Lozano, A.M., Tasker, R.R., Lang, A.E., and Dostrovsky, J.O., 1997, Identification and characterization of neurons with tremor-frequency activity in human globus pallidus, Exp. Brain Res. 113:557.

    Article  PubMed  CAS  Google Scholar 

  • Kaneoke, Y., and Vitek, J.L., 1996, Burst and oscillation as disparate neuronal properties, J. Neurosci. Methods 68:211.

    Article  PubMed  CAS  Google Scholar 

  • Keefe, K.A., and Gerfen, C.R., 1996, D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors, J. Comp. Neurol. 367:165.

    Article  PubMed  CAS  Google Scholar 

  • Keefe, K.A., and Ganguly, A., 1998, Effects of NMDA receptor antagonists on D1 dopamine receptormediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors? Dev. Neurosci. 20:216.

    Article  PubMed  CAS  Google Scholar 

  • Klockgether, T., and Turski, L., 1989, Excitatory amino acids and the basal ganglia-implications for the therapy of Parkinson’s disease, Trends. Neurosci. 12:285.

    Article  PubMed  CAS  Google Scholar 

  • Kornhuber, J., Bormann, J., Hubers, M., Rusche, K., and Riederer, P., 1991, Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel-a human postmortem brain study, Eur. J. Pharmacol. — Molec. Pharmacol. 206:297.

    Article  CAS  Google Scholar 

  • Kornhuber, J., Schoppmeyer, K., and Riederer, P., 1993, Affinity of 1-aminoadamantanes for the sigma binding site in postmortem human frontalccortex, Neurosci. Lett. 163:129.

    Article  PubMed  CAS  Google Scholar 

  • Kreiss, D.S., Anderson, L.A., and Walters, J.R., 1996, Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons, Neuroscience 72:863.

    Article  PubMed  CAS  Google Scholar 

  • Kreiss, D.S., Mastropietro, C.W., Rawji, S.S., and Walters, J.R., 1997, The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson’s disease, J. Neurosci. 17:6807.

    PubMed  CAS  Google Scholar 

  • Lange, K.W., Kornhuber, J., and Riederer, P., 1997, Dopamine/glutamate interactions in Parkinson’s disease, Neurosci. Biobehav. Rev. 21:393.

    Article  PubMed  CAS  Google Scholar 

  • Levy, R., Dostrovsky, J.O., Land, A.E., Sime, E., Hutchison, W.D., and Lozano, A.M., 2001, Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson’s disease, J. Neurophysiol. 86:249.

    PubMed  CAS  Google Scholar 

  • Luginger, E., Wenning, G.K., Bosch, S., and Poewe, W., 2000, Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson’s disease, Mov. Disord. 15:873.

    Article  PubMed  CAS  Google Scholar 

  • Magill, P.J., Bolam, J.P., and Bevan, M.D., 2001, Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network, Neuroscience 106:313.

    Article  PubMed  CAS  Google Scholar 

  • Marin, C., Papa S., Engber, T.M., Bonastre, M., Tolosa, E., and Chase, T.N., 1996, MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats, Brain Res. 736:202.

    Article  PubMed  CAS  Google Scholar 

  • Matsubayashi, H., Swanson, K.L., and Albuquerque, E.X., 1997, Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons, J. Pharmacol. Exp. Ther. 281:834.

    PubMed  CAS  Google Scholar 

  • Metman, L.V., Del Dotto, P., Blanchet, P.J., Van den Munckhof, P., and Chase, T.N., 1998a, Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson’s disease, Amino Acids 14:75.

    Article  Google Scholar 

  • Metman, L.V., Del Dotto, P., Van den Munckhof, P., Fang, J., Mouradian, M.M., and Chase, T.N., 1998b, Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease, Neurology 50:1323.

    CAS  Google Scholar 

  • Metman, L.V., Del Dotto, P., LePoole, K., Konitsiotis, S., Fang, J., and Chase, T.N., 1999, Amantadine for levodopa-induced dyskinesias — a 1-year follow-up study, Arch. Neurol. 56:1383.

    Article  PubMed  CAS  Google Scholar 

  • Miller, W.C., and Delong, M.R., 1987, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MTPTP model of parkinsonism, in: The Basal Ganglia II, M.B. Carpenter and A. Jayaraman, eds., Plenum Press, New York, pp. 415–427.

    Google Scholar 

  • Ni, Z.G., Bouali-Benazzouz, R., Gao, D.M., Benabid, A.L., and Benazzouz, A., 2001, Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats, Brain Res. 899:142.

    Article  PubMed  CAS  Google Scholar 

  • Oh, J.D., Russell, D., Vaughan, C.L., and Chase, T.N., 1998, Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration, Brain Res. 813:150.

    Article  PubMed  CAS  Google Scholar 

  • Oh, J.D., Vaughan, C.L., and Chase, T.N., 1999, Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits, Brain Res. 821:433.

    Article  PubMed  CAS  Google Scholar 

  • Orieux, G., Francois, C., Feger, J., Yelnik, J., Vila, M., Ruberg, M., Agid, Y., and Hirsch, E.C., 2000, Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson’s disease, Neuroscience 97:79.

    Article  PubMed  CAS  Google Scholar 

  • Ossowska, K., 1994, The role of excitatory amino acids in experimental models of Parkinson’s disease, J. Neural. Transm. PD Sect. 8:39.

    Article  CAS  Google Scholar 

  • Papa, S.M., Engber, T.M., Boldry, R.C., and Chase, T.N., 1993, Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists, Eur. J. Pharmacol. 232:247.

    Article  PubMed  CAS  Google Scholar 

  • Papa, S.M., Boldry, R.C., Engber, T.M., Kask, A.M., and Chase, T.N., 1995, Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade, Brain Res. 701:13.

    Article  PubMed  CAS  Google Scholar 

  • Papa, S.M., and Chase, T.N., 1996, Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys, Ann. Neurol. 39:574.

    Article  PubMed  CAS  Google Scholar 

  • Peeters, M., Romieu, P., Maurice, T., Su, T.P., Maloteaux, J.M., and Hermans, E., 2004, Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine, Eur. J. Neurosci. 19:2212.

    Article  PubMed  Google Scholar 

  • Pelled, G., Bergman, H., and Goelman, G., 2002, Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson’s disease — a functional magnetic resonance imaging study, Eur. J. Neurosci. 15:389.

    Article  PubMed  Google Scholar 

  • Perier, C., Agid, Y., Hirsch, E.C., and Feger, J., 2000, Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion, Neuroreport 11:3275.

    Article  PubMed  CAS  Google Scholar 

  • Rogawski, M.A., and Wenk, G.L., 2003, The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease, CNS Drug Rev. 9:275.

    Article  PubMed  CAS  Google Scholar 

  • Ruskin, D.N., Bergstrom, D.A., Kaneoke, Y., Patel, B.N., Twery, M.J., and Walters, J.R., 1999a, Multisecond oscillations in firing rate in the basal ganglia: robust modulation by dopamine receptor and anesthesia., J. Neurophysiol. 81:2046.

    PubMed  CAS  Google Scholar 

  • Ruskin, D.N., Bergstrom, D.A., and Walters, J.R., 1999b, Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 nd D2 dopamine receptors, J. Pharmacol. Exp. Ther. 290:1493.

    PubMed  CAS  Google Scholar 

  • Ruskin, D.N., Bergstrom, D.A., Baek, D., Freeman, L.E., and Walters, J.R., 2001, Cocaine or selective block of dopamine transporters influences multisecond oscillations in firing rate in the globus pallidus, Neuropsychopharmacology 25:28.

    Article  PubMed  CAS  Google Scholar 

  • Ruskin, D.N., Bergstrom, D.A., Tierney, P.L., and Walters, J.R., 2003, Correlated multisecond oscillations in firing rate in the basal ganglia: modulation by dopamine and the subthalamic nucleus, Neuroscience 117:427.

    Article  PubMed  CAS  Google Scholar 

  • Schwab, R.S., England, A.C., Jr., Poskanzer, D.C., and Young, R.R., 1969, Amantadine in the treatment of Parkinson’s disease, JAMA. 208:1168.

    Article  PubMed  CAS  Google Scholar 

  • Schwab, R.S., Poskanzer, D.C., England, A.C., Jr., and Young, R.R., 1972, Amantadine in Parkinson’s disease. Review of more than two years’ experience, JAMA. 222:792.

    Article  PubMed  CAS  Google Scholar 

  • Shannon, K.M., Goetz, C.G., Carroll, V.S., Tanner, C.M., and Klawans, H.L., 1987, Amantadine and motor fluctuations in chronic Parkinson’s disease, Clin. Neuropharmacol. 10:522.

    Article  PubMed  CAS  Google Scholar 

  • Starr, M.S., 1995, Antiparkinsonian actions of glutamate antagonists-alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms, J. Neural. Transm — Park Dis. Dement Sect. 10:141.

    Article  PubMed  CAS  Google Scholar 

  • Tahar, A.H., Gregoire, L., Darre, A., Belanger, N., Meltzer, L., and Bedard, P.J., 2004, Effect on a selective glutamate antagonist on 1-dopa-induced dyskinesias in drug-naïve parkinsonian monkeys, Neurobiol. Dis. 15:171.

    Article  CAS  Google Scholar 

  • Tai, C.H., Boraud, T., Bezard, E., Bioulac, B., Gross, C., and Benazzouz, A., 2003, Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata, FASEB J. 17:1820.

    Article  PubMed  CAS  Google Scholar 

  • Vila, M., Perier, C., Feger, J., Yelnik, J., Faucheux, B., Ruberg, M., Raisman-Vozari, R., Agid, Y., and Hirsch, E.C., 2000, Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements, Eur. J. Neurosci. 12:337.

    Article  PubMed  CAS  Google Scholar 

  • Walters, J.R., Ruskin, D.N., Allers, K.A., and Bergstrom, D.A., 2000, Pre-and postsynaptic aspects of dopamine-mediated transmission, Trends Neurosci. 23:S41.

    Article  PubMed  CAS  Google Scholar 

  • Walters, J.R., Hu, D., Itoga, C.A., Parr-Brownlie, L.C., and Bergstrom, D.A., Do local field potentials reflect synchronized spiking activity of neuronal populations in the basal ganglia? Studies in a rodent model of Parkinson’s disease, in: The Basal Ganglia VIII, J.P. Bolam, P.J. Magill, and C. Ingham, eds., Springer Science and Business Media, New York, pp 37–46 (This volume).

    Google Scholar 

  • Wichmann, T., Kliem, M.A., and Soares, J., 2002, Slow oscillatory discharge in the primate basal ganglia, J. Neurophysiol. 87:1145.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Discovery Biology, Pfizer Ltd., Ramsgate Road, Sandwich, CT13 9NJ, UK

    Kelly A. Allers

  2. Dept. of Biological and Environmental Sciences, University of Tennessee at Chattanooga, 615 McCallie Avenue, 317H Holt Hall, Chattanooga, TX, 37403-2598, USA

    Deborah S. Kreiss

  3. Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Porter Neuroscience Center, Bethesda, MD, 20892-3702, USA

    Judith R. Walters

Authors
  1. Kelly A. Allers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debra A. Bergstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leyla J. Ghazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deborah S. Kreiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Judith R. Walters
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. MRC Anatomical Neuropharmacology Unit, University of Oxford, Oxford, UK

    J. Paul Bolam  & Peter J. Magill  & 

  2. Division of Veterinary Biomedical Science, University of Edinburgh, Edinburgh, UK

    Cali A. Ingham

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Allers, K.A., Bergstrom, D.A., Ghazi, L.J., Kreiss, D.S., Walters, J.R. (2005). Do Systemically Administered Glutamate Antagonists Affect Subthalamic Nucleus Activity?. In: Bolam, J.P., Ingham, C.A., Magill, P.J. (eds) The Basal Ganglia VIII. Advances in Behavioral Biology, vol 56. Springer, Boston, MA. https://doi.org/10.1007/0-387-28066-9_26

Download citation

Publish with us

Policies and ethics

Search

Navigation